Royalty Pharma Reports Q4 and Full Year 2024 Results
Provided By GlobeNewswire
Last update: Feb 11, 2025
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year 2024 and introduced full year 2025 guidance for Portfolio Receipts.
Read more at globenewswire.com33.01
-0.27 (-0.81%)
Find more stocks in the Stock Screener
RPRX Latest News and Analysis
2 days ago - ChartmillIs ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) Ready to Break Out of Its Range?Exploring ROYALTY PHARMA PLC- CL A's Technical Signals and Breakout Potential: Based on good technical signals, ROYALTY PHARMA PLC- CL A is potentially setting up for a breakout.
